Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients
Nondiabetic adults with overweight or obesity lost more weight when treated with once-weekly semaglutide than once-daily liraglutide, as demonstrated by results of the phase IIIb STEP* 8 trial.
Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients
07 Apr 2022
SGLT2i lowers serum urate regardless of diabetes status
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) can keep serum urate levels low in patients with and without diabetes, according to a recent Singapore study.
SGLT2i lowers serum urate regardless of diabetes status
06 Apr 2022
Insulin pump, CGM use linked to better glucose control during pregnancy
The use of either an insulin pump or a continuous glucose monitoring (CGM) device among pregnant women with type 1 diabetes leads to improved glycaemic control, although pump use appears to be linked to higher birth weight measures, a study has found.
Insulin pump, CGM use linked to better glucose control during pregnancy
06 Apr 2022
High-intensity statins help lower cholesterol among diabetics
Treatment with rosuvastatin, given at moderate and high intensity doses, as well as simvastatin and atorvastatin, given at high intensity doses, modestly reduce levels of nonhigh-density lipoprotein cholesterol (non-HDL-C) in diabetic patients over 12 weeks compared with placebo, a study has shown.
High-intensity statins help lower cholesterol among diabetics
05 Apr 2022
Tech-enabled, team-based approach lowers HbA1c levels in youth with T1D
In children with type 1 diabetes (T1D), glycated haemoglobin A1c (HbA1c) significantly decreases at 12 months after diagnosis with the help of a technology-enabled, team-based approach to intensified new-onset education involving target setting, continuous glucose monitoring (CGM), and remote data review, results of a study have shown.
Tech-enabled, team-based approach lowers HbA1c levels in youth with T1D
05 Apr 2022
Resistance exercise could improve sleep duration, efficiency
Individuals at elevated cardiovascular disease risk (overweight/obese, increased blood pressure levels) may improve the duration and efficiency of their sleep through regular resistance exercise regimens, according to a study presented at the EPI Lifestyle Scientific Sessions 2022.
Resistance exercise could improve sleep duration, efficiency
04 Apr 2022
Allo-HSCT recipients at higher risk of metabolic diseases
Rigorous monitoring is necessary among recipients of allogeneic haematopoietic stem cell transplantation (allo-HSCT) for the development of metabolic diseases, such as hypertension, diabetes, dyslipidaemia, and cardiovascular disease (CVD), suggests a recent study.
Allo-HSCT recipients at higher risk of metabolic diseases
04 Apr 2022
Subclinical hyperthyroidism not a risk factor for MACE in PCI patients
Subclinical hyperthyroidism (SHyper) does not independently correlate with major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI), results of a study have shown.